Hepion Pharmaceuticals, Inc. (OTC:HEPA)
Hepion Pharmaceuticals, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 6 insiders in the last 90 days.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$3.2M
- Net margin
- —
Little or no net debt.
- Total debt
- $0
- Cash
- $1.6M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $1.9M
- Current liabilities
- $493K
- Current ratio
- 3.91
Consumes cash and must keep raising it.
- Operating cash flow
- -$1.6M
- Free cash flow
- -$1.6M
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 16.2M
- Share growth (1y)
- 42.9%
- Cash runway
- 12 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
HEPA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 1.16 M | 728.51 K | 609.68 K | 527.90 K | 919.49 K | — |
| R&D Expense | 50.92 K | 70.00 K | 0.00 | 0.00 | 423.28 K | — |
| Operating Expenses | 1.21 M | 798.51 K | 609.68 K | 527.90 K | 1.34 M | — |
| Operating Income | -1.21 M | -798.51 K | -609.68 K | -527.90 K | -1.34 M | — |
| Pretax Income | -1.25 M | -810.79 K | -656.88 K | -472.51 K | -1.04 M | — |
| Tax Provision | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.25 M | -810.79 K | -656.88 K | -472.51 K | -1.04 M | — |
| EPS (Basic) | -0.08 | -0.07 | — | -0.04 | -0.09 | -2.15 |
| EPS (Diluted) | -0.08 | -0.07 | — | -0.04 | -0.09 | -2.15 |
| Shares Outstanding | 16.19 M | 11.62 M | — | 11.62 M | 11.33 M | 2.84 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.